Top Markets
Coin of the day
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Rang in Aktien #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Aktienkurs
$61.73
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$1.01B
Veränderung (1 Tag)
-1.02%
Veränderung (1 Jahr)
5.10%
Land
DK
Handel Gubra A/S (GUBRA)

Kategorie

Dividendenrendite-Verlauf für Gubra A/S (GUBRA)
Dividendenrendite (TTM) von Gubra A/S (Aktienkürzel: GUBRA) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Gubra A/S (GUBRA) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH